In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their vacci-nation status. We estimated vaccine effectiveness (VE) against infection and onwards transmission, con-trolling for previous infections, household-exposure and temporal trends. We included 301,741 tests from 25 January to 24 June 2021. Full-schedule vaccination was associated with significant protection against infection. In addition, mRNA-vaccines reduced onward transmission: VE-estimates increased to >90% when index and contact were fully vaccinated. The small number of viral-vector vaccines included limited interpretability. (C) 2021 The Author(s). Published by Elsevier Ltd
peer reviewedAim: The Belgium’s strategy against COVID-19 was partly based on mass screening. Here, ...
As national coronavirus disease 2019 (COVID-19) mass vaccination campaigns are rolled out, monitorin...
textabstractBackground:The aim of the present study was to estimate the effectiveness of the MF59™-a...
In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their ...
BACKGROUND: During the first half of 2021, we observed high vaccine effectiveness (VE) against SARS-...
BACKGROUND: Contact tracing is one of the main public health tools in the control of coronavirus dis...
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vac...
BACKGROUND: With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
By employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
The computer simulation presented in this study aimed to investigate the effect of contact tracing o...
The national vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the pres...
Background We provide national estimates of the real-world Vaccine effectiveness (VE) based on natio...
BackgroundTo inform public health policy, it is critical to monitor coronavirus disease 2019 vaccine...
peer reviewedAim: The Belgium’s strategy against COVID-19 was partly based on mass screening. Here, ...
As national coronavirus disease 2019 (COVID-19) mass vaccination campaigns are rolled out, monitorin...
textabstractBackground:The aim of the present study was to estimate the effectiveness of the MF59™-a...
In Belgium, high-risk contacts of an infected person were offered PCR-testing irrespective of their ...
BACKGROUND: During the first half of 2021, we observed high vaccine effectiveness (VE) against SARS-...
BACKGROUND: Contact tracing is one of the main public health tools in the control of coronavirus dis...
This paper uses large cross-country data for 110 countries to examine the effectiveness of COVID vac...
BACKGROUND: With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
By employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain...
The objective of this study was to investigate the incidence and risk factors associated with COVID-...
The computer simulation presented in this study aimed to investigate the effect of contact tracing o...
The national vaccination campaign against SARS-CoV-2 started in January 2021 in Belgium. In the pres...
Background We provide national estimates of the real-world Vaccine effectiveness (VE) based on natio...
BackgroundTo inform public health policy, it is critical to monitor coronavirus disease 2019 vaccine...
peer reviewedAim: The Belgium’s strategy against COVID-19 was partly based on mass screening. Here, ...
As national coronavirus disease 2019 (COVID-19) mass vaccination campaigns are rolled out, monitorin...
textabstractBackground:The aim of the present study was to estimate the effectiveness of the MF59™-a...